MyFinsight
Home
About
Contact
gild: the income statement
Download
Download image
Rest Of World
$5M
(-99.46%↓ Y/Y)
Europe
$411M
(-64.38%↓ Y/Y)
US
$7M
(-99.87%↓ Y/Y)
Rest Of World
$928M
(0.00%↑ Y/Y)
Europe
$1,144M
(-0.87%↓ Y/Y)
US
$5,274M
(-2.93%↓ Y/Y)
Royalty Contract And
Other
$424M
(1313.33%↑ Y/Y)
Product
$7,345M
(-2.26%↓ Y/Y)
Total revenues
$7,769M
(2.97%↑ Y/Y)
Other (income)
expense, net
$569M
(85.95%↑ Y/Y)
Operating income (loss)
$3,327M
(274.66%↑ Y/Y)
Total costs and
expenses
$4,442M
(-33.27%↓ Y/Y)
Income (loss) before
income taxes
$3,641M
(280.86%↑ Y/Y)
Interest expense
$256M
(7.56%↑ Y/Y)
Selling, general and
administrative expenses
$1,357M
(-5.30%↓ Y/Y)
Acquired in-process
research and development...
$170M
(-66.34%↓ Y/Y)
Research and development
expenses
$1,346M
(-3.51%↓ Y/Y)
Cost of goods sold
$1,569M
(-0.32%↓ Y/Y)
Net income (loss)
$3,052M
(143.58%↑ Y/Y)
Income tax expense
(benefit)
$589M
(298.32%↑ Y/Y)
Net income (loss)
attributable to gilead
$3,052M
(143.58%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)